Orion Investment Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Orion Investment Company's BMY Position: Q1 2026 in Review
Orion Investment Company increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q1 2026, buying an estimated $23.6K and bringing the position to 22,553 shares worth $1.37M. The position accounts for 0.43% of the portfolio, ranked #39.
Orion Investment Company first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.54M in Q1 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Orion Investment Company held 22,553 shares of Bristol-Myers Squibb worth $1.37M as of Q1 2026.
- Orion Investment Company bought 405 Bristol-Myers Squibb shares in Q1 2026, an estimated $23.6K.
- Bristol-Myers Squibb made up 0.43% of Orion Investment Company's portfolio in Q1 2026, its #39 holding.
- Orion Investment Company first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
- Orion Investment Company's Bristol-Myers Squibb position peaked at $1.54M in Q1 2025.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Orion Investment Company's 13F filing for Q1 2026, filed 12 May 2026.